Kim HJ - Search Results

1

Prognostic impact of minimal pleural effusion in non-small-cell lung cancer.

Ryu JS, Ryu HJ, Lee SN, Memon A, Lee SK, Nam HS, Kim HJ, Lee KH, Cho JH, Hwang SS. Ryu JS, et al. Among authors: kim hj. J Clin Oncol. 2014 Mar 20;32(9):960-7. doi: 10.1200/JCO.2013.50.5453. Epub 2014 Feb 18. J Clin Oncol. 2014. PMID: 24550423

2

Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.

Kim JS, Cho MS, Nam JH, Kim HJ, Choi KW, Ryu JS. Kim JS, et al. Among authors: kim hj. PLoS One. 2017 May 9;12(5):e0177015. doi: 10.1371/journal.pone.0177015. eCollection 2017. PLoS One. 2017. PMID: 28486527 Free PMC article.

3

Gender as an independent prognostic factor in small-cell lung cancer: Inha Lung Cancer Cohort study using propensity score matching.

Lim JH, Ryu JS, Kim JH, Kim HJ, Lee D. Lim JH, et al. Among authors: kim hj, kim jh. PLoS One. 2018 Dec 11;13(12):e0208492. doi: 10.1371/journal.pone.0208492. eCollection 2018. PLoS One. 2018. PMID: 30533016 Free PMC article.

4

Effect of BRCA1 haplotype on survival of non-small-cell lung cancer patients treated with platinum-based chemotherapy.

Kim HT, Lee JE, Shin ES, Yoo YK, Cho JH, Yun MH, Kim YH, Kim SK, Kim HJ, Jang TW, Kwak SM, Kim CS, Ryu JS. Kim HT, et al. Among authors: kim yh, kim cs, kim hj, kim sk. J Clin Oncol. 2008 Dec 20;26(36):5972-9. doi: 10.1200/JCO.2008.16.6496. Epub 2008 Nov 17. J Clin Oncol. 2008. PMID: 19018088

5

Differential effect of polymorphisms of CMPK1 and RRM1 on survival in advanced non-small cell lung cancer patients treated with gemcitabine or taxane/cisplatinum.

Ryu JS, Shin ES, Nam HS, Yi HG, Cho JH, Kim CS, Kim HJ, Lee JE. Ryu JS, et al. Among authors: kim cs, kim hj. J Thorac Oncol. 2011 Aug;6(8):1320-9. doi: 10.1097/JTO.0b013e3182208e26. J Thorac Oncol. 2011. PMID: 21642870 Free article.

6

Lack of association of genetic variations of deoxycytidine kinase with toxicity or survival of non-small-cell lung cancer patients treated with gemcitabine plus cisplatin.

Ryu JS, Kim HJ, Shin ES, Nam HS, Cho JH, Lee JE. Ryu JS, et al. Among authors: kim hj. Oncol Res. 2012;20(1):25-30. doi: 10.3727/096504012x13425470196137. Oncol Res. 2012. PMID: 23035362

7

Multiple hypercoagulability disorders at presentation of non-small-cell lung cancer.

Lee JM, Lim JH, Kim JS, Park JS, Memon A, Lee SK, Nam HS, Cho JH, Kwak SM, Lee HL, Kim HJ, Hong GJ, Ryu JS. Lee JM, et al. Among authors: kim hj, kim js. Tuberc Respir Dis (Seoul). 2014 Jul;77(1):34-7. doi: 10.4046/trd.2014.77.1.34. Epub 2014 Jul 31. Tuberc Respir Dis (Seoul). 2014. PMID: 25114702 Free PMC article.

8

Minimal Pleural Effusion in Small Cell Lung Cancer: Proportion, Mechanisms, and Prognostic Effect.

Ryu JS, Lim JH, Lee JM, Kim WC, Lee KH, Memon A, Lee SK, Yi BR, Kim HJ, Hwang SS. Ryu JS, et al. Among authors: kim hj, kim wc. Radiology. 2016 Feb;278(2):593-600. doi: 10.1148/radiol.2015142388. Epub 2015 Aug 31. Radiology. 2016. PMID: 26323029

9

Interpretation of a heterogeneous radiological response as tumor heterogeneity or a non-tumor diagnosis: A case report.

Ryu JS, Kim L, Kim WC, Kim JS, Memon A, Yi BR, Kim HJ. Ryu JS, et al. Among authors: kim hj, kim js, kim wc, kim l. Oncol Lett. 2015 Nov;10(5):2953-2956. doi: 10.3892/ol.2015.3709. Epub 2015 Sep 16. Oncol Lett. 2015. PMID: 26722270 Free PMC article.

10

Dramatic response of acute disseminated intravascular coagulation to erlotinib in a patient with lung adenocarcinoma with activating EGFR mutation.

Kim JS, Ryu JS, Jeon SH, Kim HJ, Nam HS, Cho JH, Kwak SM, Lee HL. Kim JS, et al. Among authors: kim hj. J Int Med Res. 2018 Jan;46(1):533-537. doi: 10.1177/0300060517720099. Epub 2017 Jul 21. J Int Med Res. 2018. PMID: 28730909 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21,021 results

Search Page